The CHO Cell Culture Media Market expansion is fueled by surging demand for biologics, biosimilars, and cell-based therapies. Monoclonal antibody production accounts for approximately 40.4% of total market applications, reflecting the critical role of CHO cells in therapeutic protein manufacturing. Rising prevalence of chronic diseases and cancer drives investment in biopharmaceutical...